Can fluoxetine mitigate mental health decline in musculoskeletal trauma patients: a pilot single-center randomized clinical trial

Elizabeth Lossada-Soto, Marissa Pazik, Mary Beth Horodyski, Terrie Vasilopoulos, Ludmila Barbosa de Faria, Carol Mathews, Jennifer Hagen, Elizabeth Lossada-Soto, Marissa Pazik, Mary Beth Horodyski, Terrie Vasilopoulos, Ludmila Barbosa de Faria, Carol Mathews, Jennifer Hagen

Abstract

Background: Musculoskeletal trauma is one of the leading causes of disability in the USA and its negative quality of life impact extends beyond that of physical recovery. More than 50% of victims of musculoskeletal trauma suffer lasting mental health issues and post-traumatic stress disorder (PTSD) symptomology following their injury. These symptoms can develop across all spectrums of patients and are independent predictors of poor outcome. Access to mental health care is limited, expensive, and time intensive, and a large majority of the trauma population do not get to utilize this valuable resource. This leaves the burden of management on the orthopedic team, as they are often the only point of contact for the patient within the medical system.

Methods: This is a single-center, repeated measures, randomized controlled pilot study including up to 100 orthopedic trauma patients aged between 18 and 85 years of age. Subjects are approached during their index hospitalization and are randomized to one of two pharmaceutical interventions, fluoxetine (also known as Prozac) or calcium, for 9 months. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that is supported for the treatment of PTSD by the American Psychiatric Association. It is low-cost and has minimal side effects and withdrawal symptoms if stopped suddenly. Calcium is a supplement with minimal side effects that is used in our study for its bone-healing potential. Feasibility will be indexed by recruitment feasibility, randomization feasibility, medical adherence, anti-depressant side effects, and fracture union rate. Subjects will complete physical and mental health surveys at baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year.

Discussion: The goals of this exploratory clinical trial are to: develop a safe, feasible, and time-limited protocol effect of immediate (post-injury) treatment with fluoxetine for use by orthopedic providers and other non-mental health care providers treating victims of musculoskeletal trauma (Aim 1), and test the for preliminary effects of the protocol on development of PTSD symptomology and physical recovery in these patients (Aim 2). This study is novel in that it strives to prevent the development of symptomology from the time of injury and empowers surgeons to manage their patients in a more holistic manner.

Trial registration: ClinicalTrials.gov, NCT04850222 . Registered on April 20, 2021.

Keywords: Anxiety; Depression; Fluoxetine; Mental health; Orthopedic trauma; Post-traumatic stress disorder (PTSD); Prozac.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Study flow diagram
Fig. 2
Fig. 2
Drug administration timeline (*Referral to primary care physician if needed for further mental health treatment)
Fig. 3
Fig. 3
Group mean difference in BDI-II by timepoint

References

    1. Vincent HK, Horodyski M, Vincent KR, Brisbane ST, Sadasivan KK. Psychological distress after orthopedic trauma: prevalence in patients and implications for rehabilitation. PM R. 2015;7(9):978–989. doi: 10.1016/j.pmrj.2015.03.007.
    1. Mitchell C, . PAHO/WHO | Mental health problems are the leading cause of disability worldwide, say experts at PAHO Directing Council side event.: Pan American Health Organization / World Health Organization; 2019. Available from: . Cited 2021 Aug 10
    1. Zdziarski-Horodyski L, Vasilopoulos T, Horodyski M, Hagen JE, Sadasivan KS, Sharififar S, et al. Can an integrative care approach improve physical function trajectories after orthopaedic trauma? A randomized controlled trial. Clin Orthop. 2020;478(4):792–804. doi: 10.1097/CORR.0000000000001140.
    1. Burns A, Banerjee S, Morris J, Woodward Y, Baldwin R, Proctor R, et al. Treatment and prevention of depression after surgery for hip fracture in older people: randomized, controlled trials. J Am Geriatr Soc. 2007;55(1):75–80. doi: 10.1111/j.1532-5415.2007.01016.x.
    1. Grassi L, Nanni MG, Rodin G, Li M, Caruso R. The use of antidepressants in oncology: a review and practical tips for oncologists. Ann Oncol Off J Eur Soc Med Oncol. 2018;29(1):101–111. doi: 10.1093/annonc/mdx526.
    1. Wakida EK, Talib ZM, Akena D, Okello ES, Kinengyere A, Mindra A, et al. Barriers and facilitators to the integration of mental health services into primary health care: a systematic review. Syst Rev. 2018;7(1):211. doi: 10.1186/s13643-018-0882-7.
    1. Rodriguez JJ, Kohn R. Use of mental health services among disaster survivors. Curr Opin Psychiatry. 2008;21(4):370–378. doi: 10.1097/YCO.0b013e328304d984.
    1. Fluoxetine (oral route) description and brand names - Mayo Clinic. Available from: . Cited 2021 Aug 10.
    1. Wernicke JF. Safety and side effect profile of fluoxetine. Expert Opin Drug Saf. 2004;3(5):495–504. doi: 10.1517/14740338.3.5.495.
    1. Are you getting enough calcium?. Mayo Clinic. Available from: . Cited 2021 Aug 10.
    1. Penckofer S, Kouba J, Byrn M, Ferrans CE. Vitamin D and depression: where is all the sunshine? Issues Ment Health Nurs. 2010;31(6):385–393. doi: 10.3109/01612840903437657.
    1. Zdziarski-Horodyski L, Horodyski M, Sadasivan KK, Hagen J, Vasilopoulos T, Patrick M, et al. An integrated-delivery-of-care approach to improve patient reported physical function and mental wellbeing after orthopedic trauma: study protocol for a randomized controlled trial. Trials. 2018;19(1):32. doi: 10.1186/s13063-017-2430-5.
    1. Bagayogo IP, Turcios-Wiswe K, Taku K, Peccoralo L, Katz CL. Providing mental health services in the primary care setting: the experiences and perceptions of general practitioners at a New York City Clinic. Psychiatr Q. 2018;89(4):897–908. doi: 10.1007/s11126-018-9587-2.
    1. Beck AT, Steer RA, Brown GK. Beck depression inventory (BDI-II), vol. 10: San Antonio, Tx: Pearson; 1996.
    1. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897. doi: 10.1037/0022-006X.56.6.893.
    1. Foa EB, McLean CP, Zang Y, Zhong J, Rauch S, Porter K, et al. Psychometric properties of the posttraumatic stress disorder symptom scale interview for DSM–5 (PSSI–5) Psychol Assess. 2016;28(10):1159–1165. doi: 10.1037/pas0000259.
    1. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Krebs EE, Lorenz KA, Bair MJ, Damush TM, Wu J, Sutherland JM, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009;24(6):733–738. doi: 10.1007/s11606-009-0981-1.
    1. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–1194. doi: 10.1016/j.jclinepi.2010.04.011.
    1. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens Greenwich Conn. 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x.
    1. Kreidler SM, Muller KE, Grunwald GK, Ringham BM, Coker-Dukowitz ZT, Sakhadeo UR, et al. GLIMMPSE: online power computation for linear models with and without a baseline covariate. J Stat Softw. 2013;54(10):i10. doi: 10.18637/jss.v054.i10.
    1. Li G, Taljaard M, Van den Heuvel ER, Levine MA, Cook DJ, Wells GA, et al. An introduction to multiplicity issues in clinical trials: the what, why, when and how. Int J Epidemiol. 2017;46(2):746–755.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.
    1. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.
    1. Starr AJ, Smith WR, Frawley WH, Borer DS, Morgan SJ, Reinert CM, et al. Symptoms of posttraumatic stress disorder after orthopaedic trauma. J Bone Jt Surg-Am. 2004;86(6):1115–1121. doi: 10.2106/00004623-200406000-00001.
    1. Borrelli J, Starr A, Downs DL, North CS. Prospective study of the effectiveness of paroxetine on the onset of posttraumatic stress disorder, depression, and health and functional outcomes after trauma. J Orthop Trauma. 2019;33(2):e58–e63. doi: 10.1097/BOT.0000000000001342.
    1. Bertolini F, Robertson L, Bisson JI, Meader N, Churchill R, Ostuzzi G, Stein DJ, Williams T, Barbui C. Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD) (review) Cochrane Database Syst Rev. 2022;2(2):CD013443.
    1. Sharififar S, Gupta S, Vincent HK, Vasilopoulos T, Zdziarski-Horodyski L, Horodyski M, et al. How soon can we identify at-risk patients: examining initial depressive symptomology and opioid use in musculoskeletal trauma survivors? Injury. 2020;51(7):1543–1547. doi: 10.1016/j.injury.2020.04.051.
    1. Peterson BE, Jiwanlal A, Della Rocca GJ, Crist BD. Orthopedic trauma and aging. Geriatr Orthop Surg Rehabil. 2015;6(1):33–36. doi: 10.1177/2151458514565663.
    1. Program of Randomized Trials to Evaluate Pre-operative Antiseptic Skin Solutions in Orthopaedic Trauma (PREP-IT) Investigators. Slobogean GP, Sprague S, Wells J, Bhandari M, Rojas A, et al. Effectiveness of iodophor vs chlorhexidine solutions for surgical site infections and unplanned reoperations for patients who underwent fracture repair: the PREP-IT Master Protocol. JAMA Netw Open. 2020;3(4):e202215. doi: 10.1001/jamanetworkopen.2020.2215.
    1. Shiovitz TM, Bain EE, McCann DJ, Skolnick P, Laughren T, Hanina A, et al. Mitigating the effects of nonadherence in clinical trials. J Clin Pharmacol. 2016;56(9):1151–1164. doi: 10.1002/jcph.689.
    1. Smardon R. ‘I’d rather not take Prozac’: stigma and commodification in antidepressant consumer narratives. Health Interdiscip J Soc Study Health Illn Med. 2008;12(1):67–86.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться